APR — Applied Pharma Research SA is a Swiss specialty pharmaceutical company based in Balerna (Ticino). We market established therapies in pain relief, nausea and vomiting, and anorectal care, together with medical nutrition for inherited metabolic disorders, and are advancing two development-stage programs for rare conditions. APR is part of the Alpine-Bio group.
Fast-acting pain relief tablets and sachets.
Muscadvance® · Diclo-ADGC® · Itamifast® · Inflamac® · Potafast® · DialRapid®
Orodispersible films for nausea and vomiting.
Ondissolve® · Setofilm®
Cleansing foam for anorectal hygiene.
Proctoderm®
Medical foods for inherited metabolic disorders.
PKU GOLIKE® · TYR GOLIKE®
A novel sapropterin suspension formulation for the potential treatment of phenylketonuria (PKU), complementing our Golike medical nutrition franchise.
A development-stage program for epidermolysis bullosa (EB), a rare and severe dermatological condition, pursued under orphan and rare pediatric disease designations.
We are building depth in four therapeutic franchises, while expanding horizontally with a growing presence in the United States — all while continuing to serve healthcare professionals and patients across more than 15 markets worldwide.
A growing area of strategic focus as we broaden our portfolio to serve the needs of women across every life stage.
Established pain-relief therapies, led by our Diclofenac Potassium range, anchor our presence in central nervous system and pain management.
Medical nutrition for inherited metabolic disorders, led by our Golike range, alongside a growing focus on gastrointestinal and IBD-related care.
Therapies that support patients through treatment, including our Ondansetron range for nausea and vomiting and Proctoderm for anorectal care.
Questions about our products, regulatory affairs or pharmacovigilance? We're here to help.
Contact Us